Clinical trial
Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who…
NCT00490061 · Quynh-Thu Le, Other · Terminated
Key facts
| NCT number | NCT00490061 |
|---|---|
| Title | Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy |
| Official title | A Multi-Institutional Phase II Study of Radiation and GW572016 (Lapatinib) for Patients With Stage III-IV Head and Neck Cancer Who Cannot Tolerate Concurrent Chemoradiotherapy. |
| Lead sponsor | Quynh-Thu Le, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Carcinoma, Squamous Cell, Head and Neck Cancers |
| Intervention type | Device, Drug, Procedure |
| Interventions | Lapatinib, Radiotherapy (radiation), G.E. Healthcare 1.5T MR, systems revision 12.0 M5, DCE-MRI |
| Enrollment | 17 |
| Start date | Jul 1, 2007 |
| Primary completion | Jan 1, 2013 |
| Completion | Jun 1, 2016 |
| First posted | Jun 22, 2007 |
| Last update posted | Mar 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: